Next Article in Journal
Reconsidering the Tolerable Upper Levels of Zinc Intake among Infants and Young Children: A Systematic Review of the Available Evidence
Previous Article in Journal
Dietary Iron and the Elite Dancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 9
10.3390/nu14091939
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Vitamin C and Omega-3 Fatty Acid Intake Is Associated with Human Periodontitis—A Nested Case-Control Study

by
Louisa Mewes
1,2,†,
Carina Knappe
3,4,†,
Christian Graetz
1,†,
Juliane Wagner
4,5,
Tobias J. Demetrowitsch
6,
Julia Jensen-Kroll
6,
Karim Mohamed Fawzy El-Sayed
1,7,
Karin Schwarz
6,
Christof E. Dörfer
1,
Stefan Schreiber
4,8,
Matthias Laudes
3,4,8 and
Dominik M. Schulte
3,4,8,*
1
Clinic for Conservative Dentistry and Periodontology, School of Dental Medicine, Kiel University, 24105 Kiel, Germany
2
Department of Prosthodontics, Geriatric Dentistry and Craniomandibular Disorders, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 14197 Berlin, Germany
3
Institute of Diabetes and Clinical Metabolic Research, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany
4
Cluster of Excellence, Precision Medicine in Chronic Inflammation, Kiel University, 24105 Kiel, Germany
5
Department of Oral and Maxillofacial Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany
6
Department of Food Technology, Institute for Human Nutrition & Food Science, Kiel University, 24118 Kiel, Germany
7
Oral Medicine and Periodontology Department, Faculty of Dentistry, Cairo University, Giza 12613, Egypt
8
Department of Internal Medicine I, Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Schleswig-Holstein, 24105 Kiel, Germany
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Nutrients 2022, 14(9), 1939; https://doi.org/10.3390/nu14091939
Submission received: 22 March 2022 / Revised: 29 April 2022 / Accepted: 2 May 2022 / Published: 5 May 2022
(This article belongs to the Section Clinical Nutrition)
Browse Figures
Review Reports Versions Notes

Abstract

:
Vitamins and omega-3 fatty acids (Ω3FA) modulate periodontitis-associated inflammatory processes. The aim of the current investigation was to evaluate associations of oral nutrient intake and corresponding serum metabolites with clinical severity of human periodontitis. Within the Food Chain Plus cohort, 373 periodontitis patients—245 without (POL) and 128 with tooth loss (PWL)—were matched to 373 controls based on sex, smoking habit, age and body mass index in a nested case-control design. The amount of oral intake of vitamins and Ω3FAs was assessed from nutritional data using a Food Frequency Questionnaire. Oral intake and circulatory bioavailability of vitamins and Ω3FA serum metabolomics were compared, using ultra-high-resolution mass spectrometry. Periodontitis patients exhibited a significantly higher oral intake of vitamin C and Ω3FA Docosapentaenoic acid (p < 0.05) compared to controls. Nutritional intake of vitamin C was higher in PWL, while the intake of Docosapentaenoic acid was increased in POL (p < 0.05) compared to controls. In accordance, serum levels of Docosapentaenoic acid were also increased in POL (p < 0.01) compared to controls. Vitamin C and the Ω3FA Docosapentaenoic acid might play a role in the pathophysiology of human periodontitis. Further studies on individualized nutritional intake and periodontitis progression and therapy are necessary.

Graphical Abstract

1. Introduction

Periodontal disease is one of the most common chronic inflammatory diseases worldwide [1], characterized by an inflammatory progressive destruction of the tooth investing and supporting tissues, which untreated could ultimately lead to tooth loss [2].
A variety of factors have been linked to the etiology of periodontitis, including smoking, oral hygiene performance, genetic and epigenetic factors, systemic health and the patient’s nutritional status [3]. The most important behavioral factor linked to periodontitis remains routinely performed oral hygiene [4], and population-based interventions attempt to address behavioral factors to control periodontitis through legislation (antismoking, reduced sugar content in foods and drinks), restrictions (taxes on sugar and tobacco), guidelines and campaigns [5]. Although their preventive efficacy remains unclear, it seems indisputable that nutrition plays an important role in the course of systemic diseases [6]. It was postulated that oxidative stress promotes periodontal inflammation, and reduced levels of vitamin C [7,8,9,10] or increased levels of Ω6FAs [11,12] were associated with the greater severity of periodontitis and periodontal destruction. Although a systemic supplementation of vitamin C and E [13,14,15], D [16,17] or Ω3FAs [18] could reduce the risk of periodontitis and periodontal inflammation, or improve periodontal therapy outcomes, these effects seemed to wear off after a follow-up time of eight months [19].
Currently, the standardized periodontal therapy relies on manual supra- and subgingival debridement, with additional supportive antibiotic therapy under strictly defined clinical situations. However, once periodontitis is diagnosed, a common claim is to consider additional benefits of controlling the patients’ nutrition in combination with periodontal therapy [5]. The aims of the study were, therefore, (I) to evaluate the nutritional intake, especially of vitamins and fatty acids among a population with and without periodontal disease, (II) to investigate metabolite concentrations of candidate nutritional components resulting from (I), and (III) to look for associations between the nutritional profile and periodontal health.

2. Materials and Methods

2.1. Recruitment

Recruitment, phenotyping of dental status, questionnaire and matching periodontitis patients to controls were performed as published by Schulz et al. [20]. In brief, the nested case-control study was performed within the Kiel Food Chain Plus (FoCus) cohort. The FoCus cohort is located in the north of Germany, and 1837 participants were recruited between 2011 and 2014 [21,22]. While most participants were enrolled via the regional registration office, 511 subjects were recruited from the obesity outpatient clinic of the University Hospital of Schleswig-Holstein, Kiel, Germany. Subjects were extensively phenotyped including anthropometric measurements, nutritional habits and metabolomics. The overall aim of the FoCus cohort is to enable research into so-called metabolic inflammation. Parts of the questionnaire consisted of questions regarding dental status.

2.2. Phenotyping of Dental Status and Questionnaire

Phenotyping of dental status was performed via questionnaires as described before [20]. In brief, the participants were asked the following questions: Has periodontitis (gum disease) been diagnosed by a physician? If yes, in which year has periodontitis been diagnosed or how old were you? Have you been or are you undergoing dental treatment because of periodontitis? Did you lose teeth due to periodontitis (gum disease with progressed tooth loosening)? Participants were excluded from further analyses when statements were inconsistent. Only subjects who answered all of the questions negatively were accepted as potential controls [20].

2.3. Matching Periodontitis Patients to Controls

Clustering patients from the FoCus cohort according to their oral health status, 373 periodontally diseased patients were identified. These patients were further stratified into two groups: periodontitis patients without tooth loss (POL, n= 245) and periodontitis patients with tooth loss (PWL, n = 128). For comparability, 373 controls (COL, CWL) were matched (1:1) according to the gender, smoking, age and BMI of the periodontally diseased patients in a nested case-control design. The basic characteristics of the 373 identified periodontally diseased patients and their controls can be found in the manuscript of Schulz et al. [20].

2.4. Diet Acquisition

To record dietary habits, the scientifically recognized EPIC (European Prospective Investigation into Cancer and Nutrition) Nutrition Frequency Questionnaire, developed by the German Institute for Human Nutrition (DIfE) in Potsdam, was employed and has been validated, showing moderate, acceptable relative validity [23,24]. The questionnaire comprised specific questions on typical portion sizes and consumption frequency of the participants, who were asked to make retrospective statements about their previous year’s nutrition. Food intake frequencies and portion sizes were translated by the DIfE using EPIC-Soft, integrating the German food code (Bundeslebensmittelschlüssel, vII.3), into quantities of single nutrients in grams per day, e.g., a specific amino acid or specific polyunsaturated fatty acids.

2.5. Blood Sample Preparation

All blood samples were stored at −80 °C until the day of sample preparation. To avoid batch effects, all samples were randomly prepared and later measured. For sample preparation, an adapted version of the SIMPLEX-protocol from Matyash [25], a liquid–liquid extraction protocol, was used. From 100 µL blood samples, a lipophilic Methyl tert-butyl ether (MTBE) phase, a hydrophilic methanol-water phase and a protein pellet were obtained. All liquid phases were dried under vacuum (SpeedVac from Thermo Fisher, Henningsdorf, Germany) and resuspended with the following liquids: the lipophilic phase with isopropanol: chloroform (3:1) with 0.1% acetic acid; the hydrophilic phase with water/methanol (50/50, v/v) with 0.1% acetic acid. To each sample, 4 µL of an internal standard mixture was added, containing 13C-labeled tyrosine and tryptophan. The lipophilic samples were diluted in isopropanol/chloroform (3:1, v/v). The internal standard for these samples was synthetic lipids PC 5:0, PC 11:0, PC 19:0 and PG 17:0. All samples were then stored at −80 °C until the day of measurements.

2.6. Blood Sample Measurement and Data Evaluation

An FT-ICR-MS (7 Tesla, SolariXR, Bruker, Bremen, Germany) in the flow-injection mode (an HPLC 1260 Infinity from Agilent, Waldbronn, Germany) was used for the analyses. The eluent was water/methanol (50/50, v/v) with 0.1% acetic acid. The samples were ionized with an electrospray ionization source (in both modes) and a detection range of 65–950 m/z. The average resolution at 400 m/z was 600,000. The main instrument parameters were dry gas temperature (nitrogen) of 200 °C at 4 L min−1; nebulizer 1 bar; time-of-flight time section 0.35 ms and quadrupole mass 150 m/z with an RF frequency of 2 MHz, and detector sweep excitation power of 18%. The data evaluation was conducted with DataAnalysis 5.0 and MetaboScape 4.0.1 both from Bruker (Bremen, Germany). Sum formulas were calculated based on the mass error and isotopic fine structure. To reduce false-positive results, the seven golden rules of Kind and Fiehn were used [26]. In addition, annotation was conducted with customized databases by suspected targeted methods.

2.7. Statistical Analysis

The Statistical analyses and graphics were carried out with R [27]. A Shapiro–Wilk test was used to verify normality of the data. Wilcoxon–Mann–Whitney tests were used for group comparisons and p-values < 0.05 were considered significant. Multiple testing corrections for the subgroups of polyunsaturated fatty acids and vitamins of the nutritional data were performed using the Bonferroni method. Metabolite concentrations were detectable in only a limited number of subjects; therefore, instead of group comparisons, regression models were applied taking the matching factors (BMI, age, gender, smoking) as confounders into account. Metabolites below the limit of detection (1,000,000 counts) were set to NA. Metabolites were log-transformed. Logistic regression (C and P, C and POL, C and PWL) was performed using generalized linear models with family = binomial from the R stats package 3.4.4.

3. Results

The potential confounders (BMI, age, gender, smoking habits) served as matching criteria and were not significantly different between patients and controls (Table 1). Comparison of the two patient groups (POL vs. PWL) demonstrated significantly more smokers (63% vs. 75%, p = 0.038) and a higher age (56 (48–65) versus 63 (55–69) years, Median (IQR), p = 3.9 × 10−5) in the PWL group.

3.1. Daily Calorie Intake Showed No Difference between Periodontal Health and Disease

Food frequency questionnaire data were available from 652 subjects (326 sex-, smoker-, age- and BMI-matched pairs), 40% men and 65% smokers (Table 1). The average calorie intake of 9022 (7541–10,976) kJ/day in the periodontitis group (P) was not significantly higher than the daily calorie intake of their respective controls (C) with 8546 (7002–10,591) kJ/day (p = 0.054, Figure 1a). Furthermore, no significant differences in daily calorie intake were detected between POL and PWL compared to the pair-matched controls (COL, CWL) (p = 0.24; p = 0.11). Finally, no statistically significant difference in food intake in grams per day, independent of the energy content, could be observed overall (P/C), as well as between the groups POL/COL and PWL/CWL (Figure 1b).

3.2. Minerals, Protein, Carbohydrates and Fibers

No significant differences in the intake of minerals (p = 0.13), proteins (p = 0.08), carbohydrates (p = 0.26) and fibers (p = 0.34) between P and C could be demonstrated (Table 2).

3.3. Vitamin C Intake Is Increased in Subjects with Periodontitis

In general, P showed a significantly higher intake of organic acids in total compared to C (median difference: 9.24%, p = 0.02; Figure 2a), with no significant differences observed in the subgroups POL and PWL compared to pair-matched controls. In more detail, comparison of daily vitamin C intake suggested higher levels (median difference: 11.19%) in periodontally diseased patients compared to pair-matched controls (p(nom) = 0.007, p(corrected) = 0.091; Figure 2b). Here, a significantly elevated daily vitamin C intake in the PWL group (median difference: 11.48%) compared to CWL was detected (p = 0.022, Figure 2b). Additionally, vitamin D (p(nom) = 0.033) exhibited an increase in its uptake in P compared to C, which cannot be found within the subgroups POL and PWL compared to their controls. No significant differences could be demonstrated for the intake of vitamin A, B1, B12, B2, B3, B5, B6, B7, B9, E and K (Table 2).

3.4. Fatty Acids

Overall, no significant differences were detected in the total uptake of fatty acids between P and C (p = 0.058), as well as for polyunsaturated- (p = 0.08; Figure 2c), monounsaturated- (p = 0.057) and saturated fatty acids (p = 0.86). However, more detailed analyses within the group of polyunsaturated fatty acids demonstrated a significantly higher intake of Docosapentaenoic acid (DPA, Ω3FA) in P compared to C (p(nom) = 0.003, p(corrected) = 0.036, Figure 2d). In detail, the intake of DPA was significantly higher in POL compared to their controls COL (p-value = 0.026, Figure 2d).
Further nominal significances comparing C and P were detected for the monounsaturated fatty acids Eicosenoic acid, Decosenoic acid and Tetracosenoic acid, as well as for the polyunsaturated fatty acids Docosahexaenoic acid, Eicodonic acid, Eicosatrienoic acid, Eicosatetraenoic acid, Octadecatetraenoic acid, Hexadecadienoic acid, Docosatetraenoic acid and Eicosadienoic acid intake. Results of all fatty acids tested are presented in Table 2. No further significances between C and P were detectable regarding the nutritional uptake of total Cholesterol (p(nom) = 0.051) and Glycerol (p(nom) = 0.054).

3.5. Serum Concentrations—Metabolome Data

To further investigate potential associations of the significant candidates from the nutrition questionnaire (vitamin C and DPA), we analyzed the corresponding metabolite concentrations. Comparing the intensities of all measured derivates of vitamin C (Ascorbic acid (Figure 3a, OR(CI) = 1.19 (0.74–1.90)), Dehydroascorbic acid, Threonate, and L-Gulonolactone), no significant differences could be observed regarding the subgroup analyses POL and PWL, and with respect to overall comparisons C/P with p = 0.35, p = 0.48, p = 0.99 and p = 0.50, respectively.
The earlier determined candidate fatty acid DPA was found to be higher in serum levels in P compared to C (p = 0.004, OR(CI) = 1.52 (1.15–2.01)), as well as within the subgroups POL and PWL (Figure 3b, OR(CI)POL= 1.39 (1.03–1.90), OR(CI)PWL = 1.88 (1.22–2.94)). EPA was found to be higher in serum levels overall in P compared to C and in the subgroup POL compared to COL (Figure 3c, OR(CI) = 1.28 (1.04–1.58), OR(CI)POL = 1.31 (1.03–1.67)).

4. Discussion

Periodontitis poses a worldwide health burden and is commonly associated with serious metabolic diseases, including type 2 diabetes mellitus (T2DM) and atherosclerosis [1,28]. T2DM and atherosclerosis are both highly connected to a misguided dietary intake and are proven to be positively influenced by conscious dietary regimes. Hence, nutritional factors could play an important role in a successful long-term medical therapy. A similar influence of a tailored diet in periodontitis could be of great interest, especially when associated with systemic ailments such as T2DM and atherosclerosis.
In the present study, we demonstrate for the first time a higher daily intake of vitamin C and DPA, an omega-3 fatty acid, in human periodontitis subjects. In detail, differences between the periodontitis groups (without and with tooth loss) compared to the matched controls (based on gender, smoking, age and BMI) could be demonstrated, where a higher vitamin C intake was associated with periodontitis patients with tooth loss and an elevated intake of DPA with periodontitis patients without tooth loss. However, from visual data inspection, we conclude that in the case of organic acids or DPA, sample size could have affected the statistical outcome, with the smaller subgroups unable to exceed significance thresholds while at the same time showing similar data distributions (Figure 2).
These findings seem to contradict those of previous studies on the effects of diet on periodontal disease [7,8,9,29], which demonstrated an elevated periodontitis risk associated with reduced vitamin C serum levels, malnutrition with a diet lacking Ω3FAs and vitamin C, and that periodontal health improvement could be achieved by their higher intake. To assess substrate uptake, these studies used serum levels of micronutrients (the substitution study method or a food frequency questionnaire). One cannot exclude the possibility that genetically determined maldigestion, malabsorption or increased metabolism could lead to significant differences between the amount of oral intake and corresponding serum levels. Not many studies compare the amount of oral intake, correspondingly measured serum levels and local availability of micronutrients, which would be essential for a completely objective comparison. In this context, the present study compared the specified amount of nutritional intake of vitamin C and DPA and its corresponding serum levels. Hereby, we were able to successfully verify our results, showing that a significant increase in serum levels of Docosapentaenoic acid in periodontitis patients with tooth loss and a trend for increased serum levels of Ascorbic acid in periodontitis patients supports the findings from the proband’s reported nutritional intake.
In addition, the overall aim of serum homeostasis needs to be considered. Humans lack Ascorbic acid reservoirs, and thus an excessive intake would not be stored, making a sufficient daily intake still essential. Moreover, positive long-term periodontitis therapy outcomes associated with an adjunctive vitamin supplementation seem to lose their effectiveness compared to short-time adjunctive supplementation and isolated long-term conventional periodontal therapy outcomes [19]. The authors suggest that a number of factors, including a tendency for recalcitrant disease to develop at this stage, could be a reason for the observed reduced improvements at the end of the study phase [19]. Due to the well-established anti-inflammatory properties of vitamin C and positive attributes associated with Ω3FAs, patients themselves could be inclined to consume more vitamin C and DPA-containing groceries to support their periodontal health/healing ability. However, daily vitamin C and omega-3 fatty acid requirement can be altered by stress, smoking, acute infections and chronic diseases. Thus, in periodontitis patients, the daily requirement is increased [6]. Therefore, despite an observed elevated intake of vitamin C and DPA in the periodontitis group compared to controls, their daily required elevated amount of vitamin C and DPA, due to the periodontal inflammatory processes, might still have not been adequately covered. An insufficient nutrient intake consistently impairs innate and adaptive immunity, including phagocytic function, cell-mediated immunity, complement system action, secretory antibody and cytokine production and function [30]. This might explain why periodontitis can occur even with an increased oral intake of vitamin C and DPA and serum levels of DPA in periodontitis patients compared to controls.
It also remains to be discussed whether altered metabolism can lead to impaired absorption or tissue delivery. An investigation demonstrated a positive association between a loss of functional variant of the SLC23A1 vitamin C transporter and periodontitis [31], suggesting that genetic factors might affect periodontitis indirectly through a lack of functional provision of important substrates. Moreover, the elevated consumption of vitamin C in PWL can also be seen as a reflection of the patient’s own increased disease awareness. Thus, patients with tooth loss might better recognize the severity and address more motivated environmental factors, such as their nutrition.
Although the evidence of influencing factors such as urban versus rural lifestyle and different socio-economic factors seems limited, the territorial limitation of the investigated cohort needs to be considered. A fish-rich diet is common in the north of Germany, offering a high source of omega-3 fatty acids, with general anti-inflammatory effect [32] and locally modulating effect on periodontitis or other chronic inflammatory disease, such as rheumatoid arthritis [33,34]. It must be noted that during filling out the questionnaire, subjects could have reflected more critically on their own nutrition or their knowledge about an existing periodontal disease, which might have encouraged them to consume healthier food. Further studies are needed, comparing the oral intake of nutrients with the corresponding systemic but also local concentrations of micronutrients such as vitamin C and DPA, in patients with a clinically and radiologically well-defined time course of periodontal disease, especially by clinicians and dieticians and not only by questionnaires, as carried out in the current investigation. On the other hand, the used questions were in line with the new classification of periodontitis [35,36], identifying severity based on tooth loss, which the patients surely recognized. It should be noted, however, that subjects could suffer from periodontal disease without being aware of it and therefore could have been, even if in part, falsely grouped as controls.
Nutritional needs differ from patient to patient and depend on a variety of factors, including physical condition, age, gender, health and the presence as well as severity of chronic disease such as periodontitis, as investigated. The results of the current investigation indicate that an extended comparison seems reasonable. The food intake in patients with periodontitis could differ in the amount needed between supplement intake and systemic provision. This paradox of micronutrients recognized as anti-inflammatory, being associated with an inflammatory disease needs to be further evaluated in a more comprehensive way, i.e., interventional studies with vitamin C or DPA being applied and examined locally or systemically in periodontitis patients. Possibly, the attempts of periodontitis patients to eat healthier with the goal to improve their dental status might, however, not be automatically mirrored by their serum metabolites availability, still failing to have a positive impact on the periodontitis of the individuals. Increasing efforts for nutrition counseling in periodontitis should gain further importance in the near future, to individualize the periodontal therapy.

5. Conclusions

In conclusion, the investigated data of this periodontitis patient cohort and controls demonstrate a relationship between nutritional intake of vitamin C and Docosapentaenoic acid (an omega-3 fatty acid) and its serum metabolite concentrations in periodontal health and disease. A significant increase in serum levels of Docosapentaenoic acid in periodontitis patients with tooth loss and a trend for increased serum levels of Ascorbic acid in periodontitis patients supports the nutritional intake findings. The present results suggest that (I) nutritional behavior might affect the disease process of periodontitis and its therapeutic treatment outcome, and (II) further studies are required to evaluate the paradox of micronutrients recognized as anti-inflammatory, being associated with an inflammatory disease and the complex relationship between dietary intake and bioavailability of micronutrients. This should lead to nutritional counseling in periodontitis patients as a part of an individualized periodontal therapy.

Author Contributions

Conceptualization, C.G. and D.M.S.; investigation, L.M. and C.K.; formal analysis, J.W., J.J.-K. and T.J.D.; resources, M.L. and K.S.; writing—original draft preparation, L.M., C.K., D.M.S., T.J.D. and C.G.; writing—review and editing, K.S., K.M.F.E.-S., C.E.D. and M.L.; visualization, C.G. and D.M.S.; funding acquisition, S.S. and M.L. All authors have read and agreed to the published version of the manuscript.

Funding

The FoCus cohort is supported by a grant from the German Federal Ministry for Education and Research (0315540A).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the local ethics committee in Kiel, Germany (A156_03; 28.07.2011) and each participant gave his or her informed consent before inclusion into the study (Clinical trial registration number: DRKS00005285).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author (D.M.S.). The data are not publicly available due to privacy or ethical restrictions.

Acknowledgments

We thank all participants of the FoCus cohort.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Kassebaum, N.J.; Bernabe, E.; Dahiya, M.; Bhandari, B.; Murray, C.J.; Marcenes, W. Global burden of severe periodontitis in 1990–2010: A systematic review and meta-regression. J. Dent. Res. 2014, 93, 1045–1053. [Google Scholar] [CrossRef] [PubMed]
  2. Armitage, G.C.; Robertson, P.B. The biology, prevention, diagnosis and treatment of periodontal diseases: Scientific advances in the United States. J. Am. Dent. Assoc. 2009, 140 (Suppl. 1), 36s–43s. [Google Scholar] [CrossRef] [PubMed]
  3. Genco, R.J.; Borgnakke, W.S. Risk factors for periodontal disease. Periodontology 2013, 62, 59–94. [Google Scholar] [CrossRef] [PubMed]
  4. Jepsen, S.; Blanco, J.; Buchalla, W.; Carvalho, J.C.; Dietrich, T.; Dorfer, C.; Eaton, K.A.; Figuero, E.; Frencken, J.E.; Graziani, F.; et al. Prevention and control of dental caries and periodontal diseases at individual and population level: Consensus report of group 3 of joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J. Clin. Periodontol. 2017, 44 (Suppl. 18), S85–S93. [Google Scholar] [CrossRef] [PubMed]
  5. Sanz, M.; Herrera, D.; Kebschull, M.; Chapple, I.; Jepsen, S.; Beglundh, T.; Sculean, A.; Tonetti, M.S.; EFP Workshop Participants; Methodological Consultants. Treatment of Stage I-III Periodontitis-The EFP S3 Level Clinical Practice Guideline. J. Clin. Periodontol. 2020, 47, 4–60. [Google Scholar] [CrossRef] [PubMed]
  6. Enwonwu, C.O.; Ritchie, C.S. Nutrition and inflammatory markers. J. Am. Dent. Assoc. 2007, 138, 70–73. [Google Scholar] [CrossRef]
  7. Lee, J.H.; Shin, M.S.; Kim, E.J.; Ahn, Y.B.; Kim, H.D. The association of dietary vitamin C intake with periodontitis among Korean adults: Results from KNHANES. PLoS ONE 2017, 12, e0177074. [Google Scholar] [CrossRef] [Green Version]
  8. Amaliya; Timmerman, M.F.; Abbas, F.; Loos, B.G.; Van der Weijden, G.A.; Van Winkelhoff, A.J.; Winkel, E.G.; Van der Velden, U. Java project on periodontal diseases: The relationship between vitamin C and the severity of periodontitis. J. Clin. Periodontol. 2007, 34, 299–304. [Google Scholar] [CrossRef]
  9. Staudte, H.; Kranz, S.; Volpel, A.; Schutze, J.; Sigusch, B.W. Comparison of nutrient intake between patients with periodontitis and healthy subjects. Quintessence Int. 2012, 43, 907–916. [Google Scholar]
  10. Kuzmanova, D.; Jansen, I.D.; Schoenmaker, T.; Nazmi, K.; Teeuw, W.J.; Bizzarro, S.; Loos, B.G.; van der Velden, U. Vitamin C in plasma and leucocytes in relation to periodontitis. J. Clin. Periodontol. 2012, 39, 905–912. [Google Scholar] [CrossRef]
  11. Iwasaki, M.; Taylor, G.W.; Moynihan, P.; Yoshihara, A.; Muramatsu, K.; Watanabe, R.; Miyazaki, H. Dietary ratio of n-6 to n-3 polyunsaturated fatty acids and periodontal disease in community-based older Japanese: A 3-year follow-up study. Prostaglandins Leukot Essent Fat. Acids 2011, 85, 107–112. [Google Scholar] [CrossRef]
  12. Ramirez-Tortosa, M.C.; Quiles, J.L.; Battino, M.; Granados, S.; Morillo, J.M.; Bompadre, S.; Newman, H.N.; Bullon, P. Periodontitis is associated with altered plasma fatty acids and cardiovascular risk markers. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 133–139. [Google Scholar] [CrossRef]
  13. Staudte, H.; Sigusch, B.W.; Glockmann, E. Grapefruit consumption improves vitamin C status in periodontitis patients. Br. Dent. J. 2005, 199, discussion 210. [Google Scholar] [CrossRef]
  14. Dodington, D.W.; Fritz, P.C.; Sullivan, P.J.; Ward, W.E. Higher Intakes of Fruits and Vegetables, beta-Carotene, Vitamin C, alpha-Tocopherol, EPA, and DHA Are Positively Associated with Periodontal Healing after Nonsurgical Periodontal Therapy in Nonsmokers but Not in Smokers. J. Nutr. 2015, 145, 2512–2519. [Google Scholar] [CrossRef] [Green Version]
  15. Muniz, F.W.; Nogueira, S.B.; Mendes, F.L.; Rosing, C.K.; Moreira, M.M.; de Andrade, G.M.; Carvalho Rde, S. The impact of antioxidant agents complimentary to periodontal therapy on oxidative stress and periodontal outcomes: A systematic review. Arch. Oral. Biol. 2015, 60, 1203–1214. [Google Scholar] [CrossRef]
  16. Woelber, J.P.; Bremer, K.; Vach, K.; Konig, D.; Hellwig, E.; Ratka-Kruger, P.; Al-Ahmad, A.; Tennert, C. An oral health optimized diet can reduce gingival and periodontal inflammation in humans—A randomized controlled pilot study. BMC Oral Health 2016, 17, 28. [Google Scholar] [CrossRef] [Green Version]
  17. Van der Velden, U.; Kuzmanova, D.; Chapple, I.L. Micronutritional approaches to periodontal therapy. J. Clin. Periodontol. 2011, 38 (Suppl. 11), 142–158. [Google Scholar] [CrossRef]
  18. Chee, B.; Park, B.; Fitzsimmons, T.; Coates, A.M.; Bartold, P.M. Omega-3 fatty acids as an adjunct for periodontal therapy-a review. Clin. Oral. Investig. 2016, 20, 879–894. [Google Scholar] [CrossRef]
  19. Chapple, I.L.; Milward, M.R.; Ling-Mountford, N.; Weston, P.; Carter, K.; Askey, K.; Dallal, G.E.; De Spirt, S.; Sies, H.; Patel, D.; et al. Adjunctive daily supplementation with encapsulated fruit, vegetable and berry juice powder concentrates and clinical periodontal outcomes: A double-blind RCT. J. Clin. Periodontol. 2012, 39, 62–72. [Google Scholar] [CrossRef]
  20. Schulz, J.; Knappe, C.; Graetz, C.; Mewes, L.; Türk, K.; Black, A.K.; Lieb, W.; Schäfer, A.S.; Fawzy El-Sayed, K.M.; Dörfer, C.E.; et al. Secreted frizzled-related protein 5 serum levels in human periodontitis-A nested case-control study. J. Clin. Periodontol. 2019, 46, 522–528. [Google Scholar] [CrossRef]
  21. Muller, N.; Schulte, D.M.; Turk, K.; Freitag-Wolf, S.; Hampe, J.; Zeuner, R.; Schroder, J.O.; Gouni-Berthold, I.; Berthold, H.K.; Krone, W.; et al. IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans. J. Lipid Res. 2015, 56, 1034–1042. [Google Scholar] [CrossRef] [Green Version]
  22. Wang, J.; Thingholm, L.B.; Skieceviciene, J.; Rausch, P.; Kummen, M.; Hov, J.R.; Degenhardt, F.; Heinsen, F.A.; Ruhlemann, M.C.; Szymczak, S.; et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat. Genet. 2016, 48, 1396–1406. [Google Scholar] [CrossRef]
  23. Bohlscheid-Thomas, S.; Hoting, I.; Boeing, H.; Wahrendorf, J. Reproducibility and relative validity of energy and macronutrient intake of a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int. J. Epidemiol. 1997, 26 (Suppl. 1), S71–S81. [Google Scholar] [CrossRef] [Green Version]
  24. Boeing, H.; Bohlscheid-Thomas, S.; Voss, S.; Schneeweiss, S.; Wahrendorf, J. The relative validity of vitamin intakes derived from a food frequency questionnaire compared to 24-hour recalls and biological measurements: Results from the EPIC pilot study in Germany. European Prospective Investigation into Cancer and Nutrition. Int. J. Epidemiol. 1997, 26, S82–S90. [Google Scholar] [CrossRef] [Green Version]
  25. Matyash, V.; Liebisch, G.; Kurzchalia, T.V.; Shevchenko, A.; Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 2008, 49, 1137–1146. [Google Scholar] [CrossRef] [Green Version]
  26. Kind, T.; Fiehn, O. Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry. BMC Bioinform. 2007, 8, 105. [Google Scholar] [CrossRef] [Green Version]
  27. R Foundation for Statistical Computin. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2015. [Google Scholar]
  28. Tonetti, M.S.; Van Dyke, T.E.; Working Group 1 of the Joint EFP/AAP Workshop. Periodontitis and atherosclerotic cardiovascular disease: Consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J. Periodontol. 2013, 84, S24–S29. [Google Scholar] [CrossRef] [PubMed]
  29. Mieko, N.; Grossi, G.S.; Dunford, D.R.; Ho, A.W.; Trevisan, M.; Genco, G.R. Dietary Vitamin C and the Risk for Periodontal Disease. J. Periodontol. 2000, 71, 1215–1223. [Google Scholar] [CrossRef]
  30. Enwonwu, C.O.; Phillips, R.S.; Falkler, W.A., Jr. Nutrition and oral infectious diseases: State of the science. Compend. Contin. Educ. Dent. 2002, 23, 431–434, 436, 438 passim; quiz 448. [Google Scholar] [PubMed]
  31. De Jong, T.M.; Jochens, A.; Jockel-Schneider, Y.; Harks, I.; Dommisch, H.; Graetz, C.; Flachsbart, F.; Staufenbiel, I.; Eberhard, J.; Folwaczny, M.; et al. SLC23A1 polymorphism rs6596473 in the vitamin C transporter SVCT1 is associated with aggressive periodontitis. J. Clin. Periodontol. 2014, 41, 531–540. [Google Scholar] [CrossRef] [PubMed]
  32. Van Woudenbergh, G.J.; Theofylaktopoulou, D.; Kuijsten, A.; Ferreira, I.; van Greevenbroek, M.M.; van der Kallen, C.J.; Schalkwijk, C.G.; Stehouwer, C.D.; Ocke, M.C.; Nijpels, G.; et al. Adapted dietary inflammatory index and its association with a summary score for low-grade inflammation and markers of glucose metabolism: The Cohort study on Diabetes and Atherosclerosis Maastricht (CODAM) and the Hoorn study. Am. J. Clin. Nutr. 2013, 98, 1533–1542. [Google Scholar] [CrossRef] [Green Version]
  33. Naqvi, A.Z.; Buettner, C.; Phillips, R.S.; Davis, R.B.; Mukamal, K.J. n-3 fatty acids and periodontitis in US adults. J. Am. Diet. Assoc. 2010, 110, 1669–1675. [Google Scholar] [CrossRef] [Green Version]
  34. Wall, R.; Ross, R.P.; Fitzgerald, G.F.; Stanton, C. Fatty acids from fish: The anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr. Rev. 2010, 68, 280–289. [Google Scholar] [CrossRef]
  35. Tonetti, M.S.; Greenwell, H.; Kornman, K.S. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J. Periodontol. 2018, 89 (Suppl. 1), S159–S172. [Google Scholar] [CrossRef] [Green Version]
  36. Papapanou, P.N.; Sanz, M.; Buduneli, N.; Dietrich, T.; Feres, M.; Fine, D.H.; Flemmig, T.F.; Garcia, R.; Giannobile, W.V.; Graziani, F.; et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Periodontol. 2018, 89 (Suppl. 1), S173–S182. [Google Scholar] [CrossRef] [Green Version]
Nutrients 14 01939 g001 550
Figure 1. Box whisker plot of daily food intake measured in (a) kilojoules and (b) grams per day of all controls (C) and periodontitis patients (P), as well as the periodontitis groups without (POL)—and with tooth loss (PWL) with pair matched controls (COL, CWL). Extreme outliers (3xIQR) are not shown in the figure but were included in the analysis. p-values for group comparison: (a) (C vs. P: p = 0.054; COL vs. POL: p = 0.23; CWL vs. PWL: p = 0.11), (b) (C vs. P: p = 0.40; COL vs. POL: p = 0.26; CWL vs. PWL p = 0.86).
Figure 1. Box whisker plot of daily food intake measured in (a) kilojoules and (b) grams per day of all controls (C) and periodontitis patients (P), as well as the periodontitis groups without (POL)—and with tooth loss (PWL) with pair matched controls (COL, CWL). Extreme outliers (3xIQR) are not shown in the figure but were included in the analysis. p-values for group comparison: (a) (C vs. P: p = 0.054; COL vs. POL: p = 0.23; CWL vs. PWL: p = 0.11), (b) (C vs. P: p = 0.40; COL vs. POL: p = 0.26; CWL vs. PWL p = 0.86).
Nutrients 14 01939 g001
Nutrients 14 01939 g002 550
Figure 2. Box whisker plot of organic acids and fatty acids between all controls (C) and periodontitis patients (P), as well as the periodontitis groups without (POL)—and with tooth loss (PWL) with pair matched controls (COL, CWL). Extreme outliers (3xIQR) are not shown in the figure but were included in the analysis. * Significant findings; (a) Dietary intake of organic acids (C vs. P: p = 0.021 *; COL vs. POL: p = 0.132; CWL vs. PWL: p = 0.083), (b) Dietary intake of vitamin C (C vs. P: p = 0.007 *; COL vs. POL: p = 0.095; CWL vs. PWL p = 0.022 *), (c) Intake of polyunsaturated fatty acids (C vs. P: p = 0.087; COL vs. POL: p = 0.385; CWL vs. PWL p = 0.113), (d) Intake of Docosapentaenoic acid (DPA) (C vs. P: p = 0.0033 *; COL vs. POL: p = 0.026 *; CWL vs. PWL p = 0.054).
Figure 2. Box whisker plot of organic acids and fatty acids between all controls (C) and periodontitis patients (P), as well as the periodontitis groups without (POL)—and with tooth loss (PWL) with pair matched controls (COL, CWL). Extreme outliers (3xIQR) are not shown in the figure but were included in the analysis. * Significant findings; (a) Dietary intake of organic acids (C vs. P: p = 0.021 *; COL vs. POL: p = 0.132; CWL vs. PWL: p = 0.083), (b) Dietary intake of vitamin C (C vs. P: p = 0.007 *; COL vs. POL: p = 0.095; CWL vs. PWL p = 0.022 *), (c) Intake of polyunsaturated fatty acids (C vs. P: p = 0.087; COL vs. POL: p = 0.385; CWL vs. PWL p = 0.113), (d) Intake of Docosapentaenoic acid (DPA) (C vs. P: p = 0.0033 *; COL vs. POL: p = 0.026 *; CWL vs. PWL p = 0.054).
Nutrients 14 01939 g002
Nutrients 14 01939 g003 550
Figure 3. Box whisker plot of Ascorbic acid (a), Docosapentaenoic (DPA), (b) and Eicosapentaenoic acid (EPA), (c). Logistic regression was applied including the matching parameters. Metabolites were log-transformed. Extreme outliers (3xIQR) are not shown in the figure but were included in the analysis. Numbers in brackets are group sizes. * denotes p-values < 0.05.
Figure 3. Box whisker plot of Ascorbic acid (a), Docosapentaenoic (DPA), (b) and Eicosapentaenoic acid (EPA), (c). Logistic regression was applied including the matching parameters. Metabolites were log-transformed. Extreme outliers (3xIQR) are not shown in the figure but were included in the analysis. Numbers in brackets are group sizes. * denotes p-values < 0.05.
Nutrients 14 01939 g003
Table
Table 1. Comparing the matching criteria between periodontitis patients and controls. Values are shown as numbers (n), percentages (%) or median (IQR). p-values were computed using Wilcoxon test or, for binomial data (gender, smoker), chi-square test.
Table 1. Comparing the matching criteria between periodontitis patients and controls. Values are shown as numbers (n), percentages (%) or median (IQR). p-values were computed using Wilcoxon test or, for binomial data (gender, smoker), chi-square test.
Periodontitis PatientsControls p-Value
All periodontitis patients (unstratified) and controls
Subjects (n)326326-
Male (%)4040p = 1
Smoker (%)6565p = 1
Age (yrs)59 (50–67)59 (50–67)p = 0.784
BMI (kg/m2)28.7 (24.9–36.9)27.5 (24.4–35.5)p = 0.087
Periodontitis without tooth loss and controls
Subjects (n)213213-
Male (%)3838p = 1
Smoker (%)6363p = 1
Age (yrs)56 (48–65)57 (49–65)p = 0.738
BMI (kg/m2)28 (24.7–36.8)27.5 (24.3–33.8)p = 0.248
Periodontitis with tooth loss and controls
Subjects (n)113113-
Male (%)4646p = 1
Smoker (%)7575p = 1
Age (yrs)63 (55–69)63 (53–70)p = 0.933
BMI (kg/m2)29.9 (25.5–37.8)27.5 (25.1–35.8)p = 0.158
Table
Table 2. Comparing components of the nutritional intake between controls (C) and periodontitis patients (P) using Wilcoxon test (uncorrected p-values are shown), p-values in bold are nominally significant and p-values marked with an asterisk (*) are robust under multiple testing according to Bonferroni method.
Table 2. Comparing components of the nutritional intake between controls (C) and periodontitis patients (P) using Wilcoxon test (uncorrected p-values are shown), p-values in bold are nominally significant and p-values marked with an asterisk (*) are robust under multiple testing according to Bonferroni method.
Component (C vs. P)p-Value Component (C vs. P)p-Value
fatty acidsAll saturated fatty acidsp = 0.086vitaminsvitaminsp = 0.020
Octadecanoic acidp = 0.057fatp = 0.058
Octanoic acidp = 0.080proteinsp = 0.077
Hexadecanoic acidp = 0.080mineralsp = 0.131
Dodecanoic acidp = 0.082carbohydratesp = 0.255
Eicosanoic acidp = 0.105fibersp = 0.342
Tetradecanoic acidp = 0.144vitamin Cp = 0.007
Decanoic acidp = 0.154vitamin Dp = 0.033
Butanoic acidp = 0.292vitamin Ep = 0.064
Heptadecanoic acidp = 0.291vitamin B5p = 0.080
Hexanoic acidp = 0.294vitamin B1p = 0.085
Pentadecanoic acidp = 0.331vitamin B6p = 0.088
Teracosanoic acidp = 0.342vitamin B9p = 0.148
Decosanoic acid p = 0.393vitamin B3p = 0.152
All monounsaturated fatty acidsp = 0.057vitamin B7p = 0.197
Eicosenoic acidp = 0.009vitamin Kp = 0.199
Decosenoic acidp = 0.011vitamin B12p = 0.232
Tetracosenic acidp = 0.015vitamin B2p = 0.326
Hexadecenoic acidp = 0.053vitamin Ap = 0.841
Octadecenoic acidp = 0.061
Heptadecenoic acid p = 0.325
Tetradecenoic acidp = 0.342
Pentadecenoic acidp = 0.344
All polyunsaturated fatty acidsp = 0.087
Docosapentaenoic acidp = 0.003 *
Docosahexaenoic acidp = 0.008
Eicodonic acidp = 0.018
Eicosatrienoic acidp = 0.018
Eicosatetraenoic acidp = 0.019
Octadecatetraenoic acidp = 0.024
Hexadecadienoic acidp = 0.025
Docosatetraenoic acidp = 0.037
Eicosadienoic acidp = 0.043
Octadecatrienoic acidp = 0.083
Octadecadienoic acidp = 0.13
Nonadecatrienoic acid p = 0.243
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mewes, L.; Knappe, C.; Graetz, C.; Wagner, J.; Demetrowitsch, T.J.; Jensen-Kroll, J.; Mohamed Fawzy El-Sayed, K.; Schwarz, K.; Dörfer, C.E.; Schreiber, S.; et al. Vitamin C and Omega-3 Fatty Acid Intake Is Associated with Human Periodontitis—A Nested Case-Control Study. Nutrients 2022, 14, 1939. https://doi.org/10.3390/nu14091939

AMA Style

Mewes L, Knappe C, Graetz C, Wagner J, Demetrowitsch TJ, Jensen-Kroll J, Mohamed Fawzy El-Sayed K, Schwarz K, Dörfer CE, Schreiber S, et al. Vitamin C and Omega-3 Fatty Acid Intake Is Associated with Human Periodontitis—A Nested Case-Control Study. Nutrients. 2022; 14(9):1939. https://doi.org/10.3390/nu14091939

Chicago/Turabian Style

Mewes, Louisa, Carina Knappe, Christian Graetz, Juliane Wagner, Tobias J. Demetrowitsch, Julia Jensen-Kroll, Karim Mohamed Fawzy El-Sayed, Karin Schwarz, Christof E. Dörfer, Stefan Schreiber, and et al. 2022. "Vitamin C and Omega-3 Fatty Acid Intake Is Associated with Human Periodontitis—A Nested Case-Control Study" Nutrients 14, no. 9: 1939. https://doi.org/10.3390/nu14091939

APA Style

Mewes, L., Knappe, C., Graetz, C., Wagner, J., Demetrowitsch, T. J., Jensen-Kroll, J., Mohamed Fawzy El-Sayed, K., Schwarz, K., Dörfer, C. E., Schreiber, S., Laudes, M., & Schulte, D. M. (2022). Vitamin C and Omega-3 Fatty Acid Intake Is Associated with Human Periodontitis—A Nested Case-Control Study. Nutrients, 14(9), 1939. https://doi.org/10.3390/nu14091939

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop